IGF-binding proteins in type 1 diabetes are more severely altered in the presence of complications
Aims: Reduced levels of free and total insulin-like growth factor 1 (IGF-I) have been observed in Type-1 Diabetes (T1D) patients. The bioavailability of IGF-I from the circulation to the target cells is controlled by multifunctional IGF binding proteins (IGFBPs). The aim of this study was to profile...
Main Authors: | Ashok eSharma, Sharad ePurohit, Shruti eSharma, Shan eBai, Wenbo eZhi, Sithara Raju ePonny, Diane eHopkins, Leigh eSteed, Bruce eBode, Stephen W Anderson, Jin-Xiong eShe |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-01-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fendo.2016.00002/full |
Similar Items
-
СOLORECTAL CANCER AND INCULIN-LIKE GROWTH FACTORS
by: A. A. Nikolayev, et al.
Published: (2015-02-01) -
CLINICAL IMPLICATIONS OF INSULIN-LIKE GROWTH FACTORS (IGF) AND IGF-BINDING PROTEINS INVESTIGATION IN PATIENTS WITH OVARIAN NEOPLASMS
by: E. S. Gershteyn, et al.
Published: (2016-02-01) -
IGF-binding protein 2 (IGFBP2) – oncogene or tumour suppressor?
by: Adam ePickard, et al.
Published: (2015-02-01) -
Receptors and binding proteins for insulin and insulin-like growth factors in the placenta of healthy mothers and mothers with insulin-dependent diabetes mellitus
by: Weber Milena, et al.
Published: (2009-01-01) -
Genetic variability in <it>IGF-1</it> and <it>IGFBP-3</it> and body size in early life
by: Poole Elizabeth M, et al.
Published: (2012-08-01)